Historical source-based research. Compilation date and financial period are different dates.
Research summary
A two-period review of COST revenue, profitability and cash conversion; reported revenue growth was 8.17%.
Period comparison
FY2025 ended 2025-08-31; the prior observation ended 2024-09-01. Revenue moved from USD 254.453 billion to USD 275.235 billion. These are annual periods, not quarterly earnings or trailing-twelve-month estimates.
Earnings bridge
Net income moved from USD 7.367 billion to USD 8.099 billion. Operating income moved from USD 9.285 billion to USD 10.383 billion. Net margin moved from 2.90% to 2.94%. A margin change identifies an outcome; its causes require management discussion and footnotes.
Cash-flow cross-check
Operating cash flow was USD 11.339 billion in the earlier period and USD 13.335 billion in the later period. Selected free cash flow was USD 6.629 billion and USD 7.837 billion, respectively. Working-capital timing can cause earnings and cash to diverge.
Interpretation and limits
A rise in reported revenue does not by itself identify organic growth. A difference in EPS can reflect share-count changes as well as operating performance. No causal claim is made from these aggregate figures.
Valuation context
Company profiles show eligible dated valuation ratios using the September 17, 2026 price snapshot and selected annual accounting denominators. Capitalization-based measures use estimates and are identified as such. These are not live, TTM or forward values. A historical-multiple series and EV/EBITDA are not available. Sector medians describe a selected sample; they do not establish fair value or expected returns.
What to monitor
Unit volumes, comparable sales, inventory, pricing and operating leverage.
Risks and uncertainties
Consumer affordability, input inflation, competitive promotions and discretionary demand.
Sources & dates
- SEC annual filing · 2025-08-31 ↗Source date 2025-10-08
- SEC annual filing · 2024-09-01 ↗Source date 2025-10-08
- SEC annual filing · 2023-09-03 ↗Source date 2025-10-08
- SEC annual filing · 2022-08-28 ↗Source date 2024-10-09
- SEC issuer record ↗Source date 2026-09-18